Stay updated with breaking news from Abt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Argyle Capital Management Inc. decreased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 32.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,615 shares of the healthcare product maker’s stock after selling 3,150 shares during the period. Argyle Capital […]
Adell Harriman & Carpenter Inc. cut its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 18,650 shares of the healthcare product maker’s stock after selling 702 shares during the quarter. Adell […]
Cornerstone Capital Inc. lowered its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 4.4% during the 4th quarter, Holdings Channel reports. The institutional investor owned 241,640 shares of the healthcare product maker’s stock after selling 11,176 shares during the quarter. Abbott Laboratories comprises about 2.9% of Cornerstone Capital Inc.’s holdings, making the stock its […]
Sector Gamma AS acquired a new stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 39,876 shares of the healthcare product maker’s stock, valued at approximately $4,389,000. Abbott Laboratories makes up 1.1% of Sector […]
IMA Wealth Inc. trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 10.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,152 shares of the healthcare product maker’s stock after selling 250 shares during the […]